Table 5.6c

Immunosuppression Use: Maintenance Between Discharge

and One Year Posttransplant, 1993 to 2002

Recipients with Kidney Transplants

		Year of Transplant
		1993	1994	1995	1996	1997	1998	1999	2000	2001	2002
Transplants		10,360	10,646	11,073	11,389	11,696	12,432	12,737	13,573	14,239	14,774
Tx With Follow-up Immunosuppression Info		9,073	9,332	9,860	10,275	10,666	11,319	11,684	12,355	13,222	13,740
Corticosteroids	Category Usage	99.7%	99.6%	99.5%	99.2%	99.1%	98.9%	98.5%	96.8%	95.6%	91.4%
	Steroids	99.7%	99.6%	99.5%	99.2%	99.1%	98.9%	98.5%	96.8%	95.6%	91.4%
Cyclosporine	Category Usage	96.3%	92.9%	89.0%	80.8%	74.4%	68.6%	63.3%	53.0%	39.4%	32.3%
	Cyclosporin	94.5%	89.8%	49.4%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Sandimmmune	4.7%	7.9%	41.8%	14.1%	9.2%	8.3%	8.5%	5.1%	3.2%	1.7%
	Neoral	0.4%	1.1%	40.1%	73.2%	69.3%	64.9%	58.9%	48.0%	31.2%	23.6%
	Gengraf	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.4%	4.3%	8.8%	9.5%
	Eon	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.2%	0.3%	0.5%
Tacrolimus	Category Usage	3.7%	9.8%	14.3%	22.1%	29.0%	36.9%	42.7%	52.7%	63.6%	69.1%
	FK506	3.7%	9.8%	14.3%	22.1%	29.0%	36.9%	42.7%	52.7%	63.6%	69.1%
Antimetabolites	Category Usage	88.3%	85.6%	74.2%	69.8%	88.2%	88.4%	88.7%	84.0%	83.3%	84.7%
	Azathioprine	87.2%	84.9%	63.1%	30.2%	20.3%	13.3%	11.0%	7.6%	6.0%	4.4%
	Mycophenolate mofetil	1.8%	1.7%	14.6%	43.0%	72.4%	79.1%	81.7%	79.4%	79.7%	82.3%
	Leflunomide	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.0%	0.2%	0.0%	0.1%
	Cytoxan	0.2%	0.4%	0.3%	0.3%	0.2%	0.3%	0.4%	0.3%	0.2%	0.1%
Other	Category Usage	0.0%	0.3%	0.3%	1.2%	2.3%	3.4%	5.2%	16.7%	21.6%	21.2%
	Rapamycin	0.0%	0.3%	0.3%	1.2%	2.3%	3.4%	5.2%	16.7%	21.6%	21.2%

Source: OPTN/SRTR Data as of May 3, 2004.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.